Q1 2023 Holdings
Filed 2023-05-15 | 202 holdings | $6.9B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $176.9M | 883,250 | 2.6% |
| Intra-Cellular Therapies Inc(ITCIEUR) | COM | 46116X101 | $177.0M | 3,268,000 | 2.6% |
| Incyte Corp(INCY) | COM | 45337C102 | $205.3M | 2,840,500 | 3.0% |
| Moderna Inc(MRNA) | COM | 60770K107 | $238.3M | 1,551,706 | 3.5% |
| Intuitive Surgical Inc(ISRG) | COM NEW | 46120E602 | $247.5M | 968,786 | 3.6% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $264.5M | 2,613,300 | 3.8% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $330.5M | 886,928 | 4.8% |
| Ionis Pharmaceuticals Inc(IONS) | COM | 462222100 | $340.0M | 9,511,900 | 4.9% |
| Vertex Pharmaceuticals Inc(VRTX) | COM | 92532F100 | $361.0M | 1,145,695 | 5.2% |